Literature DB >> 13990748

The development of a formalin-killed Rift Valley fever virus vaccine for use in man.

R RANDALL, C J GIBBS, C G AULISIO, L N BINN, V R HARRISON.   

Abstract

Entities:  

Keywords:  ARBORVIRUSES; RIFT VALLEY FEVER; VACCINES

Mesh：

Substances：

Year:  1962        PMID： 13990748

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  21 in total

1.  In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus.

Authors:  Jian Ma; Ruifeng Chen; Weijin Huang; Jianhui Nie; Qiang Liu; Youchun Wang; Xiaoming Yang
Journal:  Hum Vaccin Immunother       Date:  2019-06-20       Impact factor: 3.452

2.  Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses.

Authors:  Jessica R Harmon; Dominique J Barbeau; Stuart T Nichol; Christina F Spiropoulou; Anita K McElroy
Journal:  NPJ Vaccines       Date:  2020-02-28       Impact factor: 7.344

3.  Stability of Rift Valley fever virus at 4 C.

Authors:  D E Craig; W J Thomas; A N DeSanctis
Journal:  Appl Microbiol       Date:  1967-03

4.  Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.

Authors:  Tetsuro Ikegami; Terence E Hill; Jennifer K Smith; Lihong Zhang; Terry L Juelich; Bin Gong; Olga A L Slack; Hoai J Ly; Nandadeva Lokugamage; Alexander N Freiberg
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

Review 5.  Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.

Authors:  Kaori Terasaki; Breanna R Tercero; Shinji Makino
Journal:  Virus Res       Date:  2015-05-27       Impact factor: 3.303

Review 6.  Rift valley fever vaccines.

Authors:  Tetsuro Ikegami; Shinji Makino
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

7.  Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay.

Authors:  B Niklasson; C J Peters; M Grandien; O Wood
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

8.  Rift Valley fever: a sero-epidemiological survey among pregnant women in Mozambique.

Authors:  B Niklasson; J Liljestrand; S Bergström; C J Peters
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

Review 9.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

10.  Development of a RVFV ELISA that can distinguish infected from vaccinated animals.

Authors:  Anita K McElroy; César G Albariño; Stuart T Nichol
Journal:  Virol J       Date:  2009-08-13       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.